Torres Denice
Glaukos Corporation · Director
Torres Denice is listed in public filings as director. This Torres Denice insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Glaukos Corporation (GKOS), Celldex Therapeutics, Inc. (CLDX), and 2seventy bio, Inc. (TSVT). Investors use Torres Denice's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --24.2k shares | Grant / ExerciseMay 28, 2026 | Disclosure amount unavailable1.9k shares | -- | -- | |
| $160k3k shares | Grant / ExerciseMay 28, 2026 | $160.0K3k shares | $53.57 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --22.3k shares | Grant / ExerciseJan 2, 2026 | Disclosure amount unavailable623 shares | -- | -- | |
| $644k33k shares | Grant / ExerciseJun 5, 2025 | $644.5K33k shares | $19.53 | -- | |
| $299k3.1k shares | Grant / ExerciseMay 29, 2025 | $298.7K3.1k shares | $94.87 | -- | |
| --21.7k shares | Grant / ExerciseMay 29, 2025 | Disclosure amount unavailable2.1k shares | -- | -- | |
| --19.5k shares | OtherMay 13, 2025 | Disclosure amount unavailable19.5k shares | -- | -- | |
| --19.5k shares | OtherMay 13, 2025 | Disclosure amount unavailable12.1k shares | -- | -- | |
| $024.1k shares | OtherMay 13, 2025 | $94.7K24.1k shares | $3.93 | -- | |
| --19.6k shares | Grant / ExerciseJan 2, 2025 | Disclosure amount unavailable461 shares | -- | -- | |
| --31.6k shares | Grant / ExerciseJun 10, 2024 | Disclosure amount unavailable12.1k shares | -- | -- | |
| $95k24.1k shares | Grant / ExerciseJun 10, 2024 | $94.7K24.1k shares | $3.93 | -- |